We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Another Coronavirus Vaccine Receives Green Light for Phase 1 Trial
Another Coronavirus Vaccine Receives Green Light for Phase 1 Trial
Roche is making progress in efforts to repurpose its immunosuppressive drug Actemra (tocilizumab) for treating the coronavirus, gaining FDA approval for a phase 3 trial, the company announced Thursday.